Compliance, security, biotech to drive packaging

SECURITY. FiercePharma-Manufacturing reports that the Freedonia Group expects regulatory and standards updates regarding barrier protection, patient compliance, and counterfeiting will drive demand for enhanced-barrier plastic bottles, calendar and wallet blister packs, prefillable syringes and inhalers, track-and-trace and authentication labels, and unit-dose pouches.

ON THE RISE. Freedonia forecasts that demand for pharmaceutical packaging in the U.S. (including Puerto Rico) will rise 5.5% annually to $18.4 Billion in 2014.

COMPLIANCE. Child-resistant caps are expected to remain the top closures for oral and liquid drug containers, but will lose momentum as blister packs and pouches penetrate unit-dose applications.

GROWTH LEADERS. Prefillable syringes and vials will lead growth, however plastic bottles will remain the most widely used package for oral drugs distributed in bulk and prescription-dose volumes. Requirements for unit-dose packaging, including expanded-label content and built-in track-and-trace features, will drive blister packaging.
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026